Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20091
20102
20113
20124
20131
20142
20155
20171
20182
20192
20204
20212
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University11
Institute of Hematology & Blood Diseases Hospital, China4
Peking University People's Hospital4
Jiangsu HengRui Medicine Co., Ltd.3
First Affiliated Hospital of Suzhou Medical College2
Kyowa Kirin China Pharmaceutical Co., Ltd.2
Ming Hou2
Novartis Pharmaceuticals2
Chongqing Peg-Bio Biopharm Co., Ltd.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic39
Purpura6
Thrombocytopenia4
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.